4.1 Letter

Copper Deficiency as a Serious Complication of Anti-Copper Treatment in Wilson's Disease

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases

Michael L. Schilsky et al.

Summary: This is an executive summary of the extensively rewritten guidance on the diagnosis and management of Wilson disease. The full guidance document can be found on the American Association for the Study of Liver Diseases (AASLD) website. The summary provides an overview and guidance statements based on evidence and expert consensus opinion.

HEPATOLOGY (2023)

Review Clinical Neurology

Early neurological deterioration in Wilson's disease: a systematic literature review and meta-analysis

Agnieszka Antos et al.

Summary: The aim of this study was to evaluate the occurrence and outcome of early neurological deterioration in patients with Wilson's disease (WD). The results showed that early neurological deterioration was more common in patients with neurological WD and occurred most frequently in patients treated with d-penicillamine, trientine, or zinc salts. Further investigations are needed to differentiate the natural course of WD from treatment-related early deterioration and to develop a standard definition for treatment-induced effects.

NEUROLOGICAL SCIENCES (2023)

Review Medicine, General & Internal

Monitoring of Copper in Wilson Disease

Grazyna Gromadzka et al.

Summary: Wilson's disease (WND) is a genetic disorder affecting copper metabolism. Multiple diagnostic tools are available to diagnose and monitor WND. Laboratory tests for copper metabolism disorders play a significant role in diagnosis.

DIAGNOSTICS (2023)

Article Clinical Neurology

Can Patients with Wilson's Disease Develop Copper Deficiency?

Kevin Chevalier et al.

Summary: This study investigated the characteristics of copper deficiency (CD) in patients with Wilson's disease (WD). The symptoms of CD in WD patients mainly include anemia, neutropenia, and neurological damage. Zinc salts treatment can improve hematologic abnormalities but has limited effect on neurological symptoms.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate

Karolina Dziezyc et al.

NEUROLOGIA I NEUROCHIRURGIA POLSKA (2014)